Teva-Topilene 0.05% Ointment: Out of Specification
Brand(s)
Last updated
Summary
Product
Teva-Topilene 0.05% Ointment
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Teva-Topilene |
Teva-Topilene |
DIN 00849669 |
Ointment |
Betamethasone dipropionate 0.05% |
689122 |
Issue
The assay is out of specification in the affected lot(s).
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers, Retailers, Other (Pharmacies)
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Teva Canada Limited
30 Novopharm Court, Toronto, Ontario M1B 2K9
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-75747
Get notified
Receive notifications for new and updated recalls and alerts by category.